Back to Companies
Elicio Therapeutics, Inc.
ELTXNasdaqCIK: 0001601485
Elicio Therapeutics, Inc. (ELTX) shows 14 recent insider filings from 11 insiders, with no open-market buying or selling. Haqq Christopher (See Remarks) is the most active by dollar volume, and the single largest transaction was $598.2K by Connelly Robert. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$2.4M
Purchases
$0
Sales
$0
Unique Insiders
11
Recent Insider Trades
14 loaded
| Sep 2 | ELTX Elicio Therapeutics, Inc. | Venkatesan Jay | Director | Award | $58.7K |
| Sep 2 | ELTX Elicio Therapeutics, Inc. | WILSON KAREN J | Director | Award | $58.7K |
| Sep 2 | ELTX Elicio Therapeutics, Inc. | Nissenson Allen | Director | Award | $58.7K |
| Sep 2 | ELTX Elicio Therapeutics, Inc. | ADAMS JULIAN | Director | Award | $58.7K |
| Sep 2 | ELTX Elicio Therapeutics, Inc. | RUFFOLO ROBERT R | Director | Award | $58.7K |
| Sep 2 | ELTX Elicio Therapeutics, Inc. | Ashe Carol Gail | Director | Award | $58.7K |
| Sep 2 | ELTX Elicio Therapeutics, Inc. | Chudnovsky Yekaterina | Director, 10% Owner | Award | $58.7K |
| Jul 17 | ELTX Elicio Therapeutics, Inc. | Shah Preetam | See Remarks | Award | $194.7K |
| Jul 17 | ELTX Elicio Therapeutics, Inc. | Haqq Christopher | See Remarks | Award | $206.9K |
| Jul 17 | ELTX Elicio Therapeutics, Inc. | DeMuth Peter | Chief Scientific Officer | Award | $169.1K |
| Jul 17 | ELTX Elicio Therapeutics, Inc. | Connelly Robert | CEO, President and Director, Director | Award | $598.2K |
| Feb 3 | ELTX Elicio Therapeutics, Inc. | Haqq Christopher | See Remarks | Grant | $412.3K |
| Feb 3 | ELTX Elicio Therapeutics, Inc. | Shah Preetam | See Remarks | Grant | $388.0K |
| Dec 10 | ELTX Elicio Therapeutics, Inc. | DeMuth Peter | Chief Scientific Officer | Exercise | $3.2K |
14 filings